We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2007;167(10):986. doi:10.1001/archinte.167.10.986.
Text Size: A A A
Published online

In a randomized trial of 98 patients with type 2 diabetes mellitus, Weymiller et al found that a decision aid used by clinicians during the visit was acceptable to patients and clinicians; was able to improve patient knowledge of the potential benefits and risks of statins; effectively communicated risk information (including the absolute risk reduction in cardiovascular events expected from statin use); and led to less conflicted choices about using or not using statins. Furthermore, the trial results suggest that the use of decision aids in practice may improve short-term patient adherence to their choice of preventive medications.

Lin et al prospectively evaluated intakes of total calcium and vitamin D in relation to breast cancer incidence among more than 30 000 women 45 years or older and free of cancer at baseline from the Women's Health Study between 1993 and 2004. The authors found that higher intakes of total calcium and vitamin D were moderately associated with a lower risk of breast cancer in premenopausal women, and the lower risk was more pronounced for more aggressive tumors including larger and poorly differentiated breast tumors. By contrast, intakes of both nutrients were not inversely associated with the risk of breast cancer among postmenopausal women. These findings suggest that calcium and vitamin D may have the potential utility in reducing the risk of breast cancer in younger women.

Colonization pressure is recognized as a risk factor for acquiring methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus. Dubberke et al examine whether Clostridium difficile–associated disease (CDAD) pressure is a risk factor for developing CDAD. CDAD pressure is a modified form of colonization pressure in which only clinically symptomatic cases of CDAD were included to measure exposure to C difficile. Only 1 patient who developed CDAD had a CDAD pressure of zero, compared with 50% of patients who did not develop CDAD. CDAD pressure remained an independent risk factor for CDAD on multivariable analyses and was the variable most strongly associated with the development of CDAD.

This study examined the treatment patterns of of 4414 patients enrolled in the prospective, multicenter Canadian Acute Coronary Syndromes I and II Registries, in relation to risk stratification by the validated Global Registry of Acute Coronary Event risk score. Despite a substantial temporal increase in the use of cardiac catheterization during index hospitalization, this invasive procedure remained paradoxically targeted toward low-risk patients. Similar management patterns were observed with the preferential use of coronary revacularization and evidence-based medical therapies in the low-risk group. These findings highlight the need for strategies aimed at eliminating the treatment-risk paradox to improve cost-effectiveness and clinical outcome in the management of acute coronary syndromes.

To explore the cause of the treatment-risk paradox reported for patients with coronary disease, McAlister et al examined data from a prospective cohort study of 3871 consecutive patients with angiographically proven coronary disease. They found that 1 month after angiogram, high-risk patients were less likely to be taking statins compared with lower-risk patients (56% vs 64%; crude risk ratio [RR], 0.88, but this treatment-risk paradox was completely attenuated by adjusting for exertional capacity and depressive symptoms (RR, 0.99). These results were robust across drug classes: while high-risk patients were less likely to be taking angiotensin-converting enzyme inhibitors, aspirin, and statins (26% vs 32%; crude RR, 0.80), this association did not persist in the adjusted model (RR, 0.99). This suggests that the treatment-risk paradox reported in administrative database analyses may be attributable to clinical factors not typically captured in databases.

Place holder to copy figure label and caption

Odds ratio for statin prescription in patients with a high-risk Duke Coronary Index.

Graphic Jump Location


Place holder to copy figure label and caption

Odds ratio for statin prescription in patients with a high-risk Duke Coronary Index.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.